Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines

Cyclin-dependent kinase inhibitor 3 (CDKN3) belongs to the dual-specificity protein phosphatase family, which is hypothesized to regulate cell cycle progression in tumor cells. However, whether CDKN3 is a potential therapeutic target for breast cancer remains to be elucidated. The present in vitro s...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Miao, Wang, Jianguang, Chen, Yanbin, Zhang, Like, Xie, Gangqiang, Liu, Qipeng, Zhang, Ting, Yuan, Pengfei, Liu, Dechun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940103/
https://www.ncbi.nlm.nih.gov/pubmed/27314680
http://dx.doi.org/10.3892/mmr.2016.5401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940103/
https://www.ncbi.nlm.nih.gov/pubmed/27314680
http://dx.doi.org/10.3892/mmr.2016.5401

Ejemplares similares